Impact and prevention of severe exacerbations of COPD: a review of the evidence

References

• DonaldsonGCWedzichaJACOPD exacerbations – 1: epidemiologyThorax200661216416816443707
   PubMed Web of Science ®Google Scholar
• AnzuetoALeimerIKestenSImpact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomesInt J Chron Obstruct Pulmon Dis2009424525119657398
   PubMedGoogle Scholar
• EffingTWKerstjensHAMonninkhofEMDefinitions of exacerbations: does it really matter in clinical trials on COPD?Chest2009136391892319736196
   PubMed Web of Science ®Google Scholar
• SuissaSDell’AnielloSErnstPLong-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortalityThorax2012671195796322684094
   PubMed Web of Science ®Google Scholar
• EstebanCQuintanaJMMorazaJImpact of hospitalisations for exacerbations of COPD on health-related quality of lifeRespir Med200910381201120819272762
   PubMed Web of Science ®Google Scholar
• MullerovaHMaselliDJLocantoreNHospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohortChest20151474999100725356881
   PubMed Web of Science ®Google Scholar
• ToyELGallagherKFStanleyELSwensenARDuhMSThe economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a reviewCOPD20107321422820486821
   PubMedGoogle Scholar
• MiravitllesMMurioCGuerreroTGisbertRPharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPDChest200212151449145512006427
   PubMed Web of Science ®Google Scholar
• LimaFVYenTYPatelJKTrends in in-hospital outcomes among adults hospitalized with exacerbation of chronic obstructive pulmonary diseaseCOPD201512263664226263035
   PubMedGoogle Scholar
• European Respiratory SocietyAn International Comparison of COPD Care in Europe: Results of the First European COPD AuditLausanne, SwitzerlandERS2012
   Google Scholar
• Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseBethesda (MD)GOLD2017
   Google Scholar
• CelliBRMacneeWStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care ExcellenceChronic Obstructive Pulmonary Disease in Over 16s: Diagnosis and ManagementLondonNICE2010
   Google Scholar
• ZhongNMoonHSLeeKHTiotropium safety and performance in Respimat (TIOSPIR): analysis of Asian cohort of COPD patientsRespirology20162181397140327490162
   PubMed Web of Science ®Google Scholar
• ChennaPRManninoDMOutcomes of severe COPD exacerbations requiring hospitalizationSemin Respir Crit Care Med201031328629420496298
   PubMed Web of Science ®Google Scholar
• HalpinDMDecramerMCelliBKestenSLiuDTashkinDPExacerbation frequency and course of COPDInt J Chron Obstruct Pulmon Dis2012765366123055714
   PubMed Web of Science ®Google Scholar
• CoteCGDordellyLJCelliBRImpact of COPD exacerbations on patient-centered outcomesChest2007131369670417356082
   PubMed Web of Science ®Google Scholar
• Soler-CatalunaJJMartinez-GarciaMARomanSPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
   PubMed Web of Science ®Google Scholar
• McGhanRRadcliffTFishRSutherlandERWelshCMakeBPredictors of rehospitalization and death after a severe exacerbation of COPDChest200713261748175517890477
   PubMed Web of Science ®Google Scholar
• GroenewegenKHScholsAMWoutersEFMortality and mortality-related factors after hospitalization for acute exacerbation of COPDChest2003124245946712907529
   PubMed Web of Science ®Google Scholar
• GunenHHacievliyagilSSKosarFFactors affecting survival of hospitalised patients with COPDEur Respir J200526223424116055870
   PubMed Web of Science ®Google Scholar
• PiquetJChavaillonJMDavidPMartinFBlanchonFRocheNHigh-risk patients following hospitalisation for an acute exacerbation of COPDEur Respir J201342494695523349446
   PubMed Web of Science ®Google Scholar
• AlmagroPSalvadoMGarcia-VidalCRecent improvement in long-term survival after a COPD hospitalisationThorax201065429830220388752
   PubMed Web of Science ®Google Scholar
• HalpinDMortality in COPD: inevitable or preventable? Insights from the cardiovascular arenaCOPD20085318720018568843
   PubMedGoogle Scholar
• PavordIDJonesPWBurgelPRRabeKFExacerbations of COPDInt J Chron Obstruct Pulmon Dis201611Spec Iss213026937187
   PubMedGoogle Scholar
• FanVSCurtisJRTuSPMcDonellMBFihnSDUsing quality of life to predict hospitalization and mortality in patients with obstructive lung diseasesChest2002122242943612171813
   PubMed Web of Science ®Google Scholar
• MolinariNBriandCVachierIHospitalizations for COPD exacerbations: trends and determinants of deathCOPD201512662162726263032
   PubMedGoogle Scholar
• SteerJGibsonGJBourkeSCPredicting outcomes following hospitalization for acute exacerbations of COPDQJM20101031181782920660633
   PubMed Web of Science ®Google Scholar
• MiravitllesMFerrerMPontAEffect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up studyThorax200459538739515115864
   PubMed Web of Science ®Google Scholar
• SolemCTSunSXSudharshanLMacahiligCKatyalMGaoXExacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2013864165224376348
   PubMed Web of Science ®Google Scholar
• NiewoehnerDEThe impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary diseaseAm J Med200611910 Suppl 1384516996898
   PubMed Web of Science ®Google Scholar
• VerhageTBoerLMolemaJHeijdraYDekhuijzenRVercoulenJHDecline of health status sub-domains by exacerbations of chronic obstructive pulmonary disease: a prospective surveyRespiration201385323624322922171
   PubMed Web of Science ®Google Scholar
• MacDonaldMIShafuddinEKingPTChangCLBardinPGHancoxRJCardiac dysfunction during exacerbations of chronic obstructive pulmonary diseaseLancet Respir Med20164213814826781000
   PubMed Web of Science ®Google Scholar
• McAllisterDAMaclayJDMillsNLDiagnosis of myocardial infarction following hospitalisation for exacerbation of COPDEur Respir J20123951097110322323574
   PubMed Web of Science ®Google Scholar
• PatelARKowlessarBSDonaldsonGCCardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201318891091109924033321
   PubMed Web of Science ®Google Scholar
• HalpinDMDecramerMCelliBKestenSLeimerITashkinDPRisk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT trialLung2011189426126821678045
   PubMed Web of Science ®Google Scholar
• ChangCLRobinsonSCMillsGDBiochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPDThorax201166976476821474497
   PubMed Web of Science ®Google Scholar
• DonaldsonGCHurstJRSmithCJHubbardRBWedzichaJAIncreased risk of myocardial infarction and stroke following exacerbation of COPDChest201013751091109720022970
   PubMed Web of Science ®Google Scholar
• WangFChengZZWangJLHanWZSunNNIncidence of pulmonary embolism in patients with acute exacerbations of chronic obstructive pulmonary disease: a meta-analysisZhonghua Yi Xue Za Zhi2013932418681871 Chinese24124736
   PubMedGoogle Scholar
• RizkallahJManSFSinDDPrevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysisChest2009135378679318812453
   PubMed Web of Science ®Google Scholar
• LandisSHMuellerovaHManninoDMContinuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012–2013Int J Chron Obstruct Pulmon Dis2014959761124944511
   PubMed Web of Science ®Google Scholar
• MiravitllesMAnzuetoALegnaniDForstmeierLFargelMPatient’s perception of exacerbations of COPD: the PERCEIVE studyRespir Med2007101345346016938447
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTAPatelISLloyd-OwenSJWilkinsonTMWedzichaJALongitudinal changes in the nature, severity and frequency of COPD exacerbationsEur Respir J200322693193614680081
   PubMed Web of Science ®Google Scholar
• CazzolaMMacneeWMartinezFJOutcomes for COPD pharmacological trials: from lung function to biomarkersEur Respir J200831241646918238951
   PubMed Web of Science ®Google Scholar
• SullivanSDStrasselsSASmithDHCharacterization of the costs of chronic obstructive pulmonary disease (COPD) in the USEur Respir J20169Suppl 23412S
   Google Scholar
• PereraPNArmstrongEPSherrillDLSkrepnekGHAcute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortalityCOPD20129213114122409371
   PubMedGoogle Scholar
• National Health Service EnglandOverview of potential to reduce lives lost from chronic obstructive pulmonary disease (COPD)2014 Available from: https://www.england.nhs.uk/wp-content/uploads/2014/02/rm-fs-6.pdfAccessed March 11, 2016
   Google Scholar
• FordESHospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001–2012 and Nationwide Emergency Department Sample 2006–2011Chest2015147498999825375955
   PubMed Web of Science ®Google Scholar
• CelliBRBarnesPJExacerbations of chronic obstructive pulmonary diseaseEur Respir J20072961224123817540785
   PubMed Web of Science ®Google Scholar
• MiravitllesMGuerreroTMayordomoCSanchez-AgudoLNicolauFSeguJLFactors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysisRespiration200067549550111070451
   PubMed Web of Science ®Google Scholar
• Garcia-AymerichJGomezFPBenetMIdentification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypesThorax201166543043721177668
   PubMed Web of Science ®Google Scholar
• Garcia-AymerichJMonsoEMarradesRMRisk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation: EFRAM studyAm J Respir Crit Care Med200116461002100711587986
   PubMed Web of Science ®Google Scholar
• Garcia-AymerichJFarreroEFelezMAIzquierdoJMarradesRMAntoJMRisk factors of readmission to hospital for a COPD exacerbation: a prospective studyThorax200358210010512554887
   PubMed Web of Science ®Google Scholar
• Garcia-PoloCAlcazar-NavarreteBRuiz-IturriagaLAFactors associated with high healthcare resource utilisation among COPD patientsRespir Med2012106121734174223058483
   PubMed Web of Science ®Google Scholar
• AlcazarBGarcia-PoloCHerrejonAFactors associated with hospital admission for exacerbation of chronic obstructive pulmonary diseaseArch Bronconeumol2012483707622196478
   PubMed Web of Science ®Google Scholar
• BahadoriKFitzGeraldJMRisk factors of hospitalization and readmission of patients with COPD exacerbation: systematic reviewInt J Chron Obstruct Pulmon Dis20072324125118229562
   PubMedGoogle Scholar
• BarnesNCalverleyPMKaplanARabeKFChronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD surveyBMC Pulm Med2013135423971625
   PubMed Web of Science ®Google Scholar
• BensonVSMüllerováHVestboJWedzichaJAPatelAHurstJRAssociations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary diseaseRespir Med201510991147115426166017
   PubMed Web of Science ®Google Scholar
• CaoZOngKCEngPTanWCNgTPFrequent hospital readmissions for acute exacerbation of COPD and their associated factorsRespirology200611218819516548905
   PubMed Web of Science ®Google Scholar
• EisnerMDBlancPDOmachiTASocioeconomic status, race and COPD health outcomesJ Epidemiol Community Health2011651263419854747
   PubMed Web of Science ®Google Scholar
• FaganelloMMTanniSESanchezFFPelegrinoNRLuchetaPAGodoyIBODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary diseaseAm J Med Sci20103391101419926966
   PubMed Web of Science ®Google Scholar
• GadouryMASchwartzmanKRouleauMSelf-management reduces both short- and long-term hospitalisation in COPDEur Respir J200526585385716264046
   PubMed Web of Science ®Google Scholar
• GodtfredsenNSVestboJOslerMPrescottERisk of hospital admission for COPD following smoking cessation and reduction: a Danish population studyThorax2002571196797212403880
   PubMed Web of Science ®Google Scholar
• GudmundssonGGislasonTJansonCRisk factors for rehospitalisation in COPD: role of health status, anxiety and depressionEur Respir J200526341441916135721
   PubMed Web of Science ®Google Scholar
• HoogendoornMFeenstraTLHoogenveenRTAlMMölkenMRAssociation between lung function and exacerbation frequency in patients with COPDInt J Chron Obstruct Pulmon Dis2010543544421191438
   PubMedGoogle Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• KesslerRFallerMFourgautGMennecierBWeitzenblumEPredictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med199915911581649872834
   PubMed Web of Science ®Google Scholar
• KimJLeeJHKimYAssociation between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort studyBMC Pulm Med2013135123927016
   PubMed Web of Science ®Google Scholar
• LauACYamLYPoonEHospital re-admission in patients with acute exacerbation of chronic obstructive pulmonary diseaseRespir Med2001951187688411716201
   PubMed Web of Science ®Google Scholar
• NiewoehnerDELokhnyginaYRiceKRisk indexes for exacerbations and hospitalizations due to COPDChest20071311202817218552
   PubMed Web of Science ®Google Scholar
• OmachiTASarkarUYelinEHBlancPDKatzPPLower health literacy is associated with poorer health status and outcomes in chronic obstructive pulmonary diseaseJ Gen Intern Med2013281748122890622
   PubMed Web of Science ®Google Scholar
• PouwEMTen VeldeGPCroonenBHKesterADScholsAMWoutersEFEarly non-elective readmission for chronic obstructive pulmonary disease is associated with weight lossClin Nutr2000192959910867726
   PubMed Web of Science ®Google Scholar
• QureshiHSharafkhanehAHananiaNAChronic obstructive pulmonary disease exacerbations: latest evidence and clinical implicationsTher Adv Chronic Dis20145521222725177479
   PubMedGoogle Scholar
• RobertsCMLoweDBucknallCERylandIKellyYPearsonMGClinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary diseaseThorax200257213714111828043
   PubMed Web of Science ®Google Scholar
• WedzichaJABrillSEAllinsonJPDonaldsonGCMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseBMC Med20131118123945277
   PubMed Web of Science ®Google Scholar
• WongAWGanWQBurnsJSinDDvan EedenSFAcute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission ratesCan Respir J200815736136418949105
   PubMed Web of Science ®Google Scholar
• MiravitllesMCalleMAlvarez-GutierrezFGobarttELopezFMartinAExacerbations, hospital admissions and impaired health status in chronic obstructive pulmonary diseaseQual Life Res200615347148016547786
   PubMed Web of Science ®Google Scholar
• MiravitllesMGarcia-SidroPFernandez-NistalAThe chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPDInt J Chron Obstruct Pulmon Dis2015102571257926664105
   PubMed Web of Science ®Google Scholar
• BeasleyVJoshiPVSinganayagamAMolyneauxPLJohnstonSLMalliaPLung microbiology and exacerbations in COPDInt J Chron Obstruct Pulmon Dis2012755556922969296
   PubMed Web of Science ®Google Scholar
• GallegoMPomaresXEspasaMPseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factorsBMC Pulm Med20141410324964956
   PubMed Web of Science ®Google Scholar
• CortiCFallyMFabricius-BjerreAPoint-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPDInt J Chron Obstruct Pulmon Dis2016111381138927382274
   PubMed Web of Science ®Google Scholar
• SchuetzPMüllerBChrist-CrainMProcalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsCochrane Database Syst Rev20129CD00749822972110
   PubMed Web of Science ®Google Scholar
• BoersmaWGAntibiotics in acute exacerbations of COPD: the good, the bad and the uglyEur Respir J20124011322753830
   PubMed Web of Science ®Google Scholar
• WaltersJATanDJWhiteCJGibsonPGWood-BakerRWaltersEHSystemic corticosteroids for acute exacerbations of chronic obstructive pulmonary diseaseCochrane Database Syst Rev20149CD00128825178099
   PubMed Web of Science ®Google Scholar
• KiserTHAllenRRValuckRJMossMVandivierRWOutcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201418991052106424617842
   PubMed Web of Science ®Google Scholar
• WedzichaJAMiravitllesMHurstJRManagement of COPD exacerbations: a European Respiratory Society/American Thoracic Society guidelineEur Respir J2017493160079128298398
   PubMed Web of Science ®Google Scholar
• WaltersJATanDJWhiteCJWood-BakerRDifferent durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary diseaseCochrane Database Syst Rev201412CD00689725491891
   PubMed Web of Science ®Google Scholar
• BrillSEWedzichaJAOxygen therapy in acute exacerbations of chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis201491241125225404854
   PubMed Web of Science ®Google Scholar
• QuintanaJMEstebanCUnzurrunzagaAPredictive score for mortality in patients with COPD exacerbations attending hospital emergency departmentsBMC Med2014126624758312
   PubMed Web of Science ®Google Scholar
• PlantPKOwenJLElliottMWOne year period prevalence study of respiratory acidosis in acute exacerbations of COPD: implications for the provision of non-invasive ventilation and oxygen administrationThorax200055755055410856313
   PubMed Web of Science ®Google Scholar
• AustinMAWillsKEBlizzardLWaltersEHWood-BakerREffect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trialBMJ2010341c546220959284
   PubMed Web of Science ®Google Scholar
• WijesingheMPerrinKHealyBPre-hospital oxygen therapy in acute exacerbations of chronic obstructive pulmonary diseaseIntern Med J201141861862220214690
   PubMed Web of Science ®Google Scholar
• ParkerCMVoducNAaronSDWebbKAO’DonnellDEPhysiological changes during symptom recovery from moderate exacerbations of COPDEur Respir J200526342042816135722
   PubMed Web of Science ®Google Scholar
• Pinto-PlataVMLivnatGGirishMSystemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPDChest20071311374317218554
   PubMed Web of Science ®Google Scholar
• StevensonNJWalkerPPCostelloRWCalverleyPMLung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005172121510151616166620
   PubMed Web of Science ®Google Scholar
• LightowlerJVWedzichaJAElliottMWRamFSNon-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysisBMJ2003326738218512543832
   PubMed Web of Science ®Google Scholar
• KoBSAhnSLimKSKimWYLeeYSLeeJHEarly failure of noninvasive ventilation in chronic obstructive pulmonary disease with acute hypercapnic respiratory failureIntern Emerg Med201510785586026341216
   PubMed Web of Science ®Google Scholar
• ContouDFragnoliCCordoba-IzquierdoABoissierFBrun-BuissonCThilleAWNoninvasive ventilation for acute hypercapnic respiratory failure: intubation rate in an experienced unitRespir Care201358122045205223737546
   PubMed Web of Science ®Google Scholar
• PhuaJKongKLeeKHShenLLimTKNoninvasive ventilation in hypercapnic acute respiratory failure due to chronic obstructive pulmonary disease vs. other conditions: effectiveness and predictors of failureIntensive Care Med200531453353915742175
   PubMed Web of Science ®Google Scholar
• AuDHBrysonCLChienJWThe effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbationsJ Gen Intern Med200924445746319194768
   PubMed Web of Science ®Google Scholar
• DecramerMNiciLNardiniSTargeting the COPD exacerbationRespir Med2008102Suppl 1S3S1518582795
   PubMed Web of Science ®Google Scholar
• Montserrat-CapdevilaJGodoyPMarsalJRCruzISolanesMEffectiveness of influenza vaccination in preventing hospital admission due to exacerbations of chronic obstructive pulmonary diseaseEnferm Infecc Microbiol Clin20143227075 Spanish23582192
   PubMed Web of Science ®Google Scholar
• FurumotoAOhkusaYChenMAdditive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung diseaseVaccine200826334284428918585831
   PubMed Web of Science ®Google Scholar
• MaddocksMKonSSSinghSJManWDRehabilitation following hospitalization in patients with COPD: can it reduce readmissions?Respirology201520339540425529496
   PubMed Web of Science ®Google Scholar
• PuhanMAScharplatzMTroostersTSteurerJRespiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality: a systematic reviewRespir Res200565415943867
   PubMed Web of Science ®Google Scholar
• PuhanMAGimeno-SantosEScharplatzMTroostersTWaltersEHSteurerJPulmonary rehabilitation following exacerbations of chronic obstructive pulmonary diseaseCochrane Database Syst Rev201110CD00530521975749
   PubMed Web of Science ®Google Scholar
• CrinerGJBourbeauJDiekemperRLPrevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society guidelineChest2015147489494225321320
   PubMed Web of Science ®Google Scholar
• BourbeauJJulienMMaltaisFReduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management interventionArch Intern Med2003163558559112622605
   PubMed Web of Science ®Google Scholar
• RiceKLDewanNBloomfieldHEDisease management program for chronic obstructive pulmonary disease: a randomized controlled trialAm J Respir Crit Care Med2010182789089620075385
   PubMed Web of Science ®Google Scholar
• FanVSGazianoJMLewRA comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trialAnn Intern Med20121561067368322586006
   PubMed Web of Science ®Google Scholar
• ZwerinkMBrusse-KeizerMvan der ValkPDSelf management for patients with chronic obstructive pulmonary diseaseCochrane Database Syst Rev20143CD00299024665053
   PubMed Web of Science ®Google Scholar
• AaronSDManagement and prevention of exacerbations of COPDBMJ2014349g523725245156
   PubMed Web of Science ®Google Scholar
• HalpinDMVogelmeierCPieperMPMetzdorfNRichardFAnzuetoAEffect of tiotropium on COPD exacerbations: a systematic reviewRespir Med20161141827109805
   PubMed Web of Science ®Google Scholar
• BatemanEDTashkinDSiafakasNA one-year trial of tiotropium Respimat plus usual therapy in COPD patientsRespir Med2010104101460147220620037
   PubMed Web of Science ®Google Scholar
• BatemanESinghDSmithDEfficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studiesInt J Chron Obstruct Pulmon Dis2010519720820714373
   PubMedGoogle Scholar
• CasaburiRMahlerDAJonesPWA long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEur Respir J200219221722411866001
   PubMed Web of Science ®Google Scholar
• ChanCKMaltaisFSigouinCHaddonJMFordGTA randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary diseaseCan Respir J200714846547218060091
   PubMed Web of Science ®Google Scholar
• NiewoehnerDERiceKCoteCPrevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilatorAnn Intern Med2005143531732616144890
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSA 4-Year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• D’UrzoAFergusonGTvan NoordJAEfficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trialRespir Res2011712156
   Web of Science ®Google Scholar
• BrusascoVHodderRMiravitllesMKorduckiLTowseLKestenSHealth outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPDThorax200358539940412728159
   PubMed Web of Science ®Google Scholar
• DecramerMChapmanKRDahlROnce-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group studyLancet Respir Med20131752453324461613
   PubMed Web of Science ®Google Scholar
• VogelmeierCHedererBGlaabTTiotropium versus salmeterol for the prevention of exacerbations of COPDN Engl J Med2011364121093110321428765
   PubMed Web of Science ®Google Scholar
• WiseRAAnzuetoACottonDTiotropium Respimat inhaler and the risk of death in COPDN Engl J Med2013369161491150123992515
   PubMed Web of Science ®Google Scholar
• DohertyDETashkinDPKerwinEEffects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week phase III trial in subjects with moderate-to-very severe COPDInt J Chron Obstruct Pulmon Dis20127577122334769
   PubMed Web of Science ®Google Scholar
• DonohueJFNiewoehnerDBrooksJO’DellDChurchASafety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled studyRespir Res2014157825015176
   PubMed Web of Science ®Google Scholar
• WedzichaJACalverleyPMSeemungalTAHaganGAnsariZStockleyRAThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med20081771192617916806
   PubMed Web of Science ®Google Scholar
• DransfieldMTBourbeauJJonesPWOnce-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trialsLancet Respir Med20131321022324429127
   PubMed Web of Science ®Google Scholar
• SharafkhanehASouthardJGGoldmanMUryniakTMartinUJEffect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized studyRespir Med2012106225726822033040
   PubMed Web of Science ®Google Scholar
• WedzichaJADecramerMFickerJHAnalysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group studyLancet Respir Med20131319920924429126
   PubMed Web of Science ®Google Scholar
• TashkinDPDohertyDEKerwinEEfficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trialsInt J Chron Obstruct Pulmon Dis20127738622334770
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• WedzichaJABanerjiDChapmanKRIndacaterol-glycopyrronium versus salmeterol-fluticasone for COPDN Engl J Med2016374232222223427181606
   PubMed Web of Science ®Google Scholar
• BuhlRGessnerCSchuermannWEfficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority studyThorax201570431131925677679
   PubMed Web of Science ®Google Scholar
• ManninoDMYuTCZhouHHiguchiKEffects of GOLD-adherent prescribing on COPD symptom burden, exacerbations, and health care utilization in a real-world settingChronic Obstr Pulm Dis20152322323528848845
   PubMedGoogle Scholar
• RodrigoGJCastro-RodriguezJAPlazaVSafety and efficacy of combined long-acting β-agonists and inhaled corticosteroids vs long-acting β-agonists monotherapy for stable COPD: a systematic reviewChest200913641029103819633090
   PubMed Web of Science ®Google Scholar
• RabeKFUpdate on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary diseaseBr J Pharmacol20111631536721232047
   PubMed Web of Science ®Google Scholar
• Roflumilast [summary of product characteristics]Luton, UKAstraZeneca UK
   Google Scholar
• MartinezFJCalverleyPMGoehringUMBroseMFabbritLMRabeKFEffect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trialLancet2015385997185786625684586
   PubMed Web of Science ®Google Scholar
• CalverleyPMRabeKFGoehringUMKristiansenSFabbriLMMartinezFJRoflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trialsLancet2009374969168569419716960
   PubMed Web of Science ®Google Scholar
• MartinezFJRabeKFSethiSEffect of roflumilast and inhaled corticosteroid/long-acting β2-agonist on chronic obstructive pulmonary disease exacerbations (RE2SPOND): a randomized clinical trialAm J Respir Crit Care Med2016194555956727585384
   PubMed Web of Science ®Google Scholar
• WedzichaJACalverleyPMRabeKFRoflumilast: a review of its use in the treatment of COPDInt J Chron Obstruct Pulmon Dis201611819026792988
   PubMed Web of Science ®Google Scholar
• YuTFainKBoydCMBenefits and harms of roflumilast in moderate to severe COPDThorax201469761662224347460
   PubMed Web of Science ®Google Scholar
• TseHNRaiteriLWongKYHigh-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE studyChest2013144110611823348146
   PubMed Web of Science ®Google Scholar
• PelaRCalcagniAMSubiacoSIsidoriPTubaldiASanguinettiCMN-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPDRespiration199966649550010575333
   PubMed Web of Science ®Google Scholar
• PoolePBlackPNCatesCJMucolytic agents for chronic bronchitis or chronic obstructive pulmonary diseaseCochrane Database Syst Rev20128CD00128722895919
   PubMed Web of Science ®Google Scholar
• ZhengJPWenFQBaiCXTwice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trialLancet Respir Med20142318719424621680
   PubMed Web of Science ®Google Scholar
• TseHNRaiteriLWongKYNgLYYeeKSTsengCZBenefits of high-dose N-acetylcysteine to exacerbation-prone patients with COPDChest2014146361162324833327
   PubMed Web of Science ®Google Scholar
• AlbertRKConnettJBaileyWCAzithromycin for prevention of exacerbations of COPDN Engl J Med2011365868969821864166
   PubMed Web of Science ®Google Scholar
• HerathSCPoolePProphylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)Cochrane Database Syst Rev201311CD009764
   PubMed Web of Science ®Google Scholar
• NiWShaoXCaiXProphylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysisPLoS One2015103e012125725812085
   PubMed Web of Science ®Google Scholar
• PomaresXMontonCEspasaMCasabonJMonsoEGallegoMLong-term azithromycin therapy in patients with severe COPD and repeated exacerbationsInt J Chron Obstruct Pulmon Dis2011644945622003290
   PubMed Web of Science ®Google Scholar
• SeemungalTAWilkinsonTMHurstJRPereraWRSapsfordRJWedzichaJALong-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbationsAm J Respir Crit Care Med2008178111139114718723437
   PubMed Web of Science ®Google Scholar
• MiravitllesMAnzuetoAAntibiotic prophylaxis in COPD: why, when, and for whom?Pulm Pharmacol Ther20153211912324825753
   PubMed Web of Science ®Google Scholar
• MartineauARJamesWYHooperRLVitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trialLancet Respir Med20153212013025476069
   PubMed Web of Science ®Google Scholar
• LehouckAMathieuCCarremansCHigh doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trialAnn Intern Med2012156210511422250141
   PubMed Web of Science ®Google Scholar
• RafiqRAlevaFESchrumpfJAPrevention of exacerbations in patients with COPD and vitamin D deficiency through vitamin D supplementation (PRECOVID): a study protocolBMC Pulm Med20151510626399451
   PubMed Web of Science ®Google Scholar
• AlbouainiKAndronMAlahmarAEgredMβ-Blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditionsInt J Chron Obstruct Pulmon Dis20072453554018268926
   PubMedGoogle Scholar
• AndellPErlingeDSmithJGβ-Blocker use and mortality in COPD patients after myocardial infarction: a Swedish nationwide observational studyJ Am Heart Assoc201544113
   Web of Science ®Google Scholar
• SalpeterSROrmistonTMSalpeterEECardioselective β-blockers in patients with reactive airway disease: a meta-analysisAnn Intern Med2002137971572512416945
   PubMed Web of Science ®Google Scholar
• BhattSPWellsJMKinneyGLβ-Blockers are associated with a reduction in COPD exacerbationsThorax201671181426283710
   PubMed Web of Science ®Google Scholar
• ShahTChurpekMMCocaPMKonetzkaRTUnderstanding why patients with COPD get readmitted: a large national study to delineate the Medicare population for the readmissions penalty expansionChest201514751219122625539483
   PubMed Web of Science ®Google Scholar
• KrishnanJAGussinHAPrieto-CenturionVSullivanJLZaidiFThomashowBMIntegrating COPD into patient-centered hospital readmissions reduction programsChronic Obstr Pulm Dis201521708025927076
   PubMedGoogle Scholar
• Prieto-CenturionVMarkosMARameyNIInterventions to reduce rehospitalizations after chronic obstructive pulmonary disease exacerbations: a systematic reviewAnn Am Thorac Soc201411341742424423379
   PubMedGoogle Scholar
• DavisKJLandisSHOhYMContinuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countriesInt J Chron Obstruct Pulmon Dis201510395525565799
   PubMed Web of Science ®Google Scholar
• GlaabTBanikNRutschmannOTWenckerMNational survey of guideline-compliant COPD management among pneumologists and primary care physiciansCOPD20063314114817240616
   PubMedGoogle Scholar
• Lopez-CamposJLHartlSPozo-RodriguezFRobertsCMAntibiotic prescription for COPD exacerbations admitted to hospital: European COPD auditPLoS One2015104e012437425905726
   PubMed Web of Science ®Google Scholar
• MularskiRAAschSMShrankWHThe quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processesChest200613061844185017167007
   PubMed Web of Science ®Google Scholar
• MäkeläMJBackerVHedegaardMLarssonKAdherence to inhaled therapies, health outcomes and costs in patients with asthma and COPDRespir Med2013107101481149023643487
   PubMed Web of Science ®Google Scholar
• Koehorst-ter HuurneKMovigKvan der ValkPvan der PalenJBrusse-KeizerMDifferences in adherence to common inhaled medications in COPDCOPD201512664364825775100
   PubMedGoogle Scholar